EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Exploring the Role of GLP ‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review

Fiona S Gruzmark iD, Gabriela E Beraja iD, Ivan Jozic, Hadar A Lev-Tov

Wound Repair and Regeneration · 2025-09 · 33 (5)

DOI: 10.1111/wrr.70085 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Wound Repair and Regeneration, 2025-09. Verfasst von Fiona S Gruzmark und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Diabetic Foot, Wound Healing, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptide 1. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, there are 537 million people with diabetes, with an estimated 19%–344% of these people developing a diabetic foot ulcer, and 10% dying within a year of being diagnosed with a diabetic foot ulcer. Risk factors for developing a diabetic foot ulcer include age, sex, ethnicity, chronically elevated HbA 1c , smoking history, cardiovascular disease, end‐stage renal disease, and retinopathy. Diabetic foot ulcer recurrence rates are as high as 20%, and they have vast complications, including lower‐extremity amputations. More recently, there has been a surge in the use of glucagon‐like peptide 1 receptor agonists in managing diabetes and weight loss. The use of glucagon‐like peptide 1 receptor agonists in treating diabetic foot ulcers in humans has not been extensively studied, but there are reports of using glucagon‐like peptide 1 receptor agonists in other dermatologic diseases with positive outcomes, including androgenetic alopecia and hidradenitis suppurativa. This review aims to explore the potential of using systemic glucagon‐like peptide 1 receptor agonists in managing diabetic foot ulcers, describing their effects on modulating wound repair, microvascular function, neuropathic symptoms, apoptosis, weight loss, oxidative stress, and inflammation. Additionally, a systematic review, following PRISMA guidelines, was conducted assessing the rate of diabetic foot complications in patients using glucagon‐like peptide 1 receptor agonists when compared to a control group, with the results suggesting their potentially protective role. By managing multiple facets of diabetic foot ulcer pathophysiology, the use of glucagon‐like peptide 1 receptor agonists may aid in their management and thus prevent recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootWound HealingGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide 1Hypoglycemic AgentsHumans

Stichwörter der Autor:innen

GLP‐1amputationdiabetic foot ulcerssystematic reviewwound healingwound repair

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide 1Hypoglycemic Agents

Autor:innen und Institutionen

  • Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: Fiona S Gruzmark, Gabriela E Beraja

Zitieren

APA

Gruzmark, F. S., Beraja, G. E., Jozic, I., & Lev-Tov, H. A. (2025). Exploring the Role of GLP ‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review. Wound Repair and Regeneration, 33(5). https://doi.org/10.1111/wrr.70085

Vancouver

Gruzmark FS, Beraja GE, Jozic I, Lev-Tov HA. Exploring the Role of GLP ‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review. Wound Repair and Regeneration. 2025;33(5). doi:10.1111/wrr.70085

BibTeX
@article{Gruzmark2025,
  author = {Gruzmark, Fiona S and Beraja, Gabriela E and Jozic, Ivan and Lev-Tov, Hadar A},
  title = {Exploring the Role of GLP ‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review},
  journal = {Wound Repair and Regeneration},
  year = {2025},
  volume = {33},
  number = {5},
  doi = {10.1111/wrr.70085}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche